Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Proof-of-Principle Trial of Communication to Patients Receiving Predictive Genetic Risk Assessment

NCT00782366 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT00782366
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00782366 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Proof-of-Principle Trial of Communication to Patients Receiving Predictive Genetic Risk Assessment
Lead sponsor
Mayo Clinic
Phase
Observational
Overall status
Completed
Start date
March 31, 2008
Completion date
January 31, 2010
Enrollment
26 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation, breast cancer, celiac disease, colon cancer, diabetes type 2, graves disease, lung cancer, myocardial infarction, obesity, osteoarthritis, prostate cancer